Search Market Research Report
3D Printing in Healthcare Market Size, Share Global Analysis Report, 2022 – 2028
3D Printing in Healthcare Market Size, Share, Growth Analysis Report By Component (System, Materials, Services), By Technology (Droplet Deposition, Photo polymerization, Laser Beam Melting, Electronic Beam Melting (EBM), Laminated Object Manufacturing, Others), By Application (External Wearable Devices, Clinical Study Devices, Implants, Tissue Engineering), By End User (Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, Academic Institutions), and By Region - Global Industry Insights, Comparative Analysis, Trends, Statistical Research, Market Intelligence, and Forecast 2022 – 2028
Industry Insights
[212+ Pages Report] According to Facts and Factors, The Global 3D Printing in Healthcare Market size was valued at USD 1,174.60 million in 2021 and is predicted to increase at a CAGR of 19.02% to USD 3120.06 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries. The report analyses the global 3D printing in the healthcare market’s drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in 3D printing in the healthcare market.
Market Overview
3D printing, often known as additive manufacturing, is a method of creating three-dimensional solid things in the healthcare industry. It is used in the medical field to create personalized medical equipment and products. Furthermore, it has several advantages over traditional reconstructive surgeries, such as lower operating risks during difficult procedures, lower infection susceptibility, and shorter anesthetic exposure time. Moreover, advances in 3D printing, customization and personalization, increased R&D investments, the presence of a large patient pool, and an increase in biomedical applications are all propelling the industry forward.
Growth Drivers
The availability of bioprinting tissues and organs, as well as an increase in pharmaceutical applications, has the potential to drive market growth during the forecast period. In addition, significant R&D investments, rapid client development, expansion of the breadth of biomedical applications, and significant R&D activities for the advancement of 3D printers at the academic and industrial levels have all propelled the market growth. Collaborations between academic institutions, hospitals, and businesses have aided the market's expansion.
The increase in the global geriatric population is fueling the growth of the healthcare 3D printing industry. The incidence of cardiovascular, orthopedic, and other disorders has raised our risk factors, as well as the demand for 3D-printed medical products. Governments all around the world have boosted their budgets for this technology's research and development, ensuring future growth. Due to the rising quality of healthcare around the world, most individuals can now use this technology. Healthcare professionals have begun to investigate this technique in order to lessen the risks associated with anesthesia during lengthy procedures. One of the key drivers of the global 3D printing market is the reduction in cost and time for medical treatments such as transplants and surgeries, as well as the rapid development of the client base.
COVID-19 Impact
The COVID-19 pandemic has caused widespread lockdowns, affecting businesses across the board. As a result, healthcare systems are being impacted, and providing high-quality medical care and treatment to all patients has become a global concern. Due to severe shortages of hospital beds and medical equipment, the COVID-19 pandemic was an unprecedented global public health challenge. Global healthcare systems faced numerous difficult challenges during the pandemic. The need for 3D printing in the healthcare business has risen dramatically during the epidemic due to a lack of equipment. Additionally, during the pandemic, COVID-19 had a negative impact on 3D healthcare. The most major challenge is a lack of equipment for the COVID-19 war as a result of the pandemic, as well as a detrimental influence on 3D printing in the healthcare business, as manufacturers are unable to make and deliver medical supplies owing to the lockdown.
The complete research study looks at both the qualitative and quantitative aspects of 3D printing in healthcare market. Both the demand and supply sides of the market have been investigated. The demand side study examines market income in various regions before comparing it to all of the major countries. The supply side research examines the industry's top rivals, as well as their regional and global presence and strategies. Each major country in North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America is thoroughly investigated.
Segmentation Analysis
The global 3D Printing in Healthcare Market is segregated based on Component, Technology, Application and End User.
Based on Technology, the droplet deposition technology segment dominates 3D printing in healthcare market due to its widespread use in healthcare applications and high heat and chemical endurance. During the forecast period, however, electron beam melting would emerge as the fastest growing segment.
Based on the Application, external Wearable Devices led market revenue in 2021, and future growth is expected to be positive. The key driver of growth is the rising use of 3D printing technology to assist patients in dealing with physical and internal ailments. During the projection period, the Implants sub-segment is expected to develop at a healthy rate. The market has grown due to the increase in population and, as a result, the incidence of various diseases. Collaborations between companies and research institutes have also resulted in more helpful and effective technologies.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1,174.60 Million |
Projected Market Size in 2028 |
USD 3120.06 Million |
CAGR Growth Rate |
19.02% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
3D System Corporation, Exone Company, Formlabs Inc., General Electric, Materialise NV, Oxford Performance Materials, Inc., Organovo Holdings, Inc., Proto Labs, SLM Solutions Group AG, Stratasys Ltd., and Others |
Key Segment |
By Component, Technology, Application, End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Landscape
North America is expected to maintain its dominance during the forecast period because the three major North American countries considered in the report are the United States, Canada, and Mexico. North America currently dominates the overall 3D printing in healthcare market and is expected to continue to do so throughout the forecast period. This is because 3D printing technology is widely used in this region, and there are numerous collaborations between academic and commercial organizations. Furthermore, technological advancements in 3D printing, an increase in funding for advancement in 3D printers for healthcare, and an increase in the patient pool in this region have all contributed to its dominance.
Competitive Landscape
The report contains qualitative and quantitative research on the global 3D Printing in Healthcare Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.
List of Key Players in the Global 3D Printing in Healthcare Market:
- 3D System Corporation
- Exone Company
- Formlabs Inc.
- General Electric
- Materialise NV
- Oxford Performance Materials, Inc.
- Organovo Holdings, Inc.
- Proto Labs
- SLM Solutions Group AG
- Stratasys Ltd.
The global 3D printing in healthcare market is segmented as follows:
By Component Segment Analysis
- System
- Materials
- Services
By Technology Segment Analysis
- Droplet Deposition
- Photo polymerization
- Laser Beam Melting
- Electronic Beam Melting (EBM)
- Laminated Object Manufacturing
- Others
By Application Segment Analysis
- External Wearable Devices
- Clinical Study Devices
- Implants
- Tissue Engineering
By End User Segment Analysis
- Medical & Surgical Centers
- Pharmaceutical & Biotechnology Companies
- Academic Institutions
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- 3D System Corporation
- Exone Company
- Formlabs Inc.
- General Electric
- Materialise NV
- Oxford Performance Materials Inc.
- Organovo Holdings Inc.
- Proto Labs
- SLM Solutions Group AG
- Stratasys Ltd.
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors